Crossmark

Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer

Crossref DOI link: https://doi.org/10.1007/s00432-014-1738-8

Published Online: 2014-06-18

Published Print: 2014-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Litovkin, Kirill

Joniau, Steven

Lerut, Evelyne

Laenen, Annouschka

Gevaert, Olivier

Spahn, Martin

Kneitz, Burkhard

Isebaert, Sofie

Haustermans, Karin

Beullens, Monique

Van Eynde, Aleyde

Bollen, Mathieu
License Information

Text and Data Mining valid from 2014-06-18